Profile for Guatemala Patent: 201300122
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Guatemala Patent: 201300122
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,754,096 | Jul 19, 2032 | Abbvie | QULIPTA | atogepant |
| 8,754,096 | Jul 19, 2032 | Abbvie | UBRELVY | ubrogepant |
| 8,912,210 | Dec 23, 2033 | Abbvie | UBRELVY | ubrogepant |
| 9,499,545 | Nov 10, 2031 | Abbvie | QULIPTA | atogepant |
| 9,499,545 | Nov 10, 2031 | Abbvie | UBRELVY | ubrogepant |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
